☆ 4.7 Article

Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma

INTERNATIONAL JOURNAL OF NANOMEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Nanoscience & Nanotechnology

Ultrasound Microbubbles Mediated Sonosensitizer and Antibody Co-delivery for Highly Efficient Synergistic Therapy on HER2-Positive Gastric Cancer

Lihong Sun et al.

Summary: The study developed ultrasound microbubbles (TP MBs) for targeted combination of sonodynamic therapy and antibody therapy, with in vivo delivery monitored by ultrasound/fluorescence bimodal imaging. TP MBs combined with ultrasound can increase the uptake of sonosensitizers and antibodies in tumor tissue, greatly enhancing the therapeutic effect on HER2-positive gastric cancer.

ACS APPLIED MATERIALS & INTERFACES (2022)

Add to Collection

Article Engineering, Biomedical

Tumor microenvironment-responsive Ag2S-PAsp(DOX)-cRGD nanoparticles-mediated photochemotherapy enhances the immune response to tumor therapy

Ruxia Han et al.

Summary: A tumor microenvironment-responsive drug delivery system was constructed and combined with doxorubicin for tumor therapy. The system effectively utilized the advantages of photothermal effect to kill tumor cells, release of DOX, and ICD effect to activate host immune response against tumors.

BIOMATERIALS (2022)

Add to Collection

Article Pharmacology & Pharmacy

Highlights in ultrasound-targeted microbubble destruction-mediated gene/ drug delivery strategy for treatment of malignancies

Hui Li et al.

Summary: This article reviews recent developments in the application of UTMD-mediated gene and drug delivery in the diagnosis and treatment of tumors, including the concept, mechanism of action, clinical application status, and advantages of UTMD. Furthermore, future perspectives in this field are also discussed.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)

Add to Collection

Article Engineering, Biomedical

Ultrasound-triggered imaging and drug delivery using microbubble-self-aggregate complexes

In Jae Chung et al.

Summary: Co-delivering microbubbles (MBs) with anticancer drugs holds promise as a theranostic approach to enhance ultrasound contrast and drug extravasation. In this study, MB-self-aggregate complexes (MB-SAs) were fabricated for encapsulating hydrophobic drugs, demonstrating enhanced cellular uptake and tumor accumulation in vivo. The novel GC@MBs could serve as both an ultrasound contrast agent and drug carrier, with increased cytotoxicity under ultrasound flash.

JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2022)

Add to Collection

Article Chemistry, Medicinal

PD-L1 Targeting Immune-Microbubble Complex Enhances Therapeutic Index in Murine Colon Cancer Models

Daehyun Kim et al.

Summary: The development of an immune-microbubble complex (IMC) has shown promise in reducing the toxicities associated with therapeutic antibodies and enhancing efficacy when combined with focused ultrasound. This concept could potentially maximize the therapeutic potential of antibody-based treatment regimens.

PHARMACEUTICALS (2021)

Add to Collection

Article Engineering, Biomedical

Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy

Jinsheng Huang et al.

Summary: A novel nanocarrier was developed for tumor-targeted delivery in melanoma to activate anti-tumor immunity and reduce adverse effects. Additionally, combining sonodynamic therapy with immunotherapy effectively promotes anti-cancer immunity and suppresses melanoma growth.

BIOMATERIALS (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Oncology

Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice

Ningshan Li et al.

Summary: Cancer immunotherapy, particularly through ultrasound stimulated microbubble cavitation (USMC), holds promise in eradicating solid tumors by promoting tumor perfusion, increasing CD8(+) T cells infiltration, and enhancing anti-PD-L1 antibody delivery. The combination therapy of optimized USMC with anti-PD-L1 antibody not only enhances tumor perfusion and vascular normalization, but also significantly increases tumor infiltrating CD8(+) T cells, leading to greater tumor growth inhibition and longer survival compared to monotherapies.

CANCER LETTERS (2021)

Add to Collection

Article Nanoscience & Nanotechnology

Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer

Yiran Si et al.

Summary: Nanoparticle-mediated sonodynamic therapy can promote anti-tumor immune response of breast cancer cells by inhibiting cell proliferation, promoting apoptosis, increasing CD4 and CD8 T cell subsets, and reducing PD-1 positive T cells, leading to suppressed tumor growth.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)

Add to Collection

Review Pathology

Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation

Elizabeth C. Paver et al.

Summary: Immunotherapy with checkpoint inhibitors, particularly PD-1/PD-L1 inhibitors, has shown efficacy in treating non-small cell lung cancer and melanoma. As clinical trials continue to expand the approved indications for these inhibitors, pathologists need to be familiar with the different PD-L1 testing methods and their impact on therapeutic decisions.

PATHOLOGY (2021)

Add to Collection

Review Oncology

Clinical outcomes and influencing factors of PD-1/PD-L1 in hepatocellular carcinoma

Jiting Wang et al.

Summary: Hepatocellular carcinoma (HCC) has an increasing incidence globally, particularly in China where it ranks fourth among all theriomas. The main treatments for HCC are surgery and liver transplantation, but postoperative recurrence and metastasis are common. Transarterial chemoembolization is the current strategy for advanced HCC, and further research on PD-1 and PD-L1 is needed to improve outcomes.

ONCOLOGY LETTERS (2021)

Add to Collection

Article Engineering, Biomedical

Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity

Suah Yang et al.

Summary: The construction of cancer-activated DOX prodrug nanoparticles provides a promising approach to enhance anticancer immune responses while minimizing side effects and systemic immunosuppression. These nanoparticles selectively target cancer cells, inducing cytotoxicity and immunogenic cell death, leading to increased response to checkpoint inhibitor immunotherapy.

BIOMATERIALS (2021)

Add to Collection

Article Oncology

Ultrasound-Mediated Gemcitabine Delivery Reduces the Normal-Tissue Toxicity of Chemoradiation Therapy in a Muscle-Invasive Bladder Cancer Model

Jia-Ling Ruan et al.

Summary: This study investigates the use of ultrasound and microbubbles for targeted gemcitabine delivery to reduce normal-tissue toxicity in a murine orthotopic MIBC model. Results show a significant delay in tumor growth with both microbubble groups, while transient weight loss was observed but resolved within 10 days posttreatment. Ultrasound-mediated drug delivery methods did not exacerbate acute intestinal toxicity compared to conventional chemoradiation therapy.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Add to Collection

Article Oncology

A Novel Strategy Conjugating PD-L1 Polypeptide With Doxorubicin Alleviates Chemotherapeutic Resistance and Enhances Immune Response in Colon Cancer

Maolin Wang et al.

Summary: The study introduced a novel dual-functional conjugate PPA1-DOX, which achieved tumor-specific drug delivery and anti-tumor activity, providing a promising therapeutic option for colon cancer. The conjugate exhibited significant antitumor activity, high binding affinity with PD-L1, and increased infiltration of T cells in tumors, representing an effective and targeted treatment strategy.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Ultrasound-Targeted Microbubble Destruction Alleviates Immunosuppression Induced by CD71+ Erythroid Progenitor Cells and Promotes PDL-1 Blockade Immunotherapy in the Lewis Lung Cancer Model

Xi Tan et al.

Summary: The study demonstrates that targeting splenic CECs using UTMD can reduce the number of CECs, increase the frequency of CD8(+) T cells, and inhibit tumor growth. Combining UTMD with PDL-1 blockade therapy enhances IFN-gamma production and reduces ROS production, presenting new possibilities for cancer treatment.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

Nanosonosensitizers With Ultrasound-Induced Reactive Oxygen Species Generation for Cancer Sonodynamic Immunotherapy

Danling Cheng et al.

Summary: Immunotherapy is a promising strategy for cancer treatment, but it faces challenges of low immune responses and immune-related adverse events. Sonodynamic therapy combined with immunotherapy can enhance antitumor immunity, and research on nanosonosensitizers for ROS generation is ongoing.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)

Add to Collection

Review Oncology

Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives

Shirin Hafezi et al.

Summary: Apoptosis is the main form of cell death regulated by the BCL-2 family of proteins. Overexpression of antiapoptotic proteins in malignant cells offers survival advantages but also presents opportunities for targeted therapies. Studies targeting BCL-2 proteins, including the development of venetoclax, show promise for effective treatment in cancer.

CANCERS (2021)

Add to Collection

Article Engineering, Biomedical

Gemcitabine-loaded microbubble system for ultrasound imaging and therapy

Lauren J. Delaney et al.

Summary: Ultrasound imaging has many advantages, and the development of microbubble contrast agents presents new opportunities for drug delivery. Gemcitabine-loaded microbubbles show potential therapeutic effects for pancreatic cancer.

ACTA BIOMATERIALIA (2021)

Add to Collection

Article Engineering, Biomedical

Self-delivery oxidative stress amplifier for chemotherapy sensitized immunotherapy

Linping Zhao et al.

Summary: A self-delivery oxidative stress amplifier has been developed for chemotherapy sensitized immunotherapy, which can accelerate tumor cell death by breaking intracellular redox homeostasis. The amplifier is able to effectively accumulate in tumor tissues and trigger immunogenic cell death through GSH-responsive drug release.

BIOMATERIALS (2021)

Add to Collection

Review Health Care Sciences & Services

Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment

Md Abdus Subhan et al.

Summary: The article discusses the importance of nanodrugs in cancer therapy, targeting tumors through the EPR effect and addressing the lack of selectivity in traditional anticancer drugs.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo-immunotherapy

Mingxia Jiang et al.

Summary: The article highlights the importance of inducing immunogenic cell death in tumor cells through chemotherapy drugs, and the promising future and potential of chemo-immunotherapy in cancer treatment.

NANOSCALE (2021)

Add to Collection

Article Medicine, Research & Experimental

An eat me combinatory nano-formulation for systemic immunotherapy of solid tumors

Hend Mohamed Abdel-Bar et al.

Summary: The study developed a stable nucleic acid-lipid particles (SNALPs) formulation for the simultaneous delivery of ICD inducing drug and siRNA targeting CD47 for enhanced ICD. The results demonstrated the potential of this combination as a potent anti-tumor strategy for future clinical studies.

THERANOSTICS (2021)

Add to Collection

Article Multidisciplinary Sciences

Frontiers in cancer immunotherapy-a symposium report

Jennifer Cable et al.

Summary: Immunotherapy has revolutionized cancer treatment by targeting the immune system to recognize and destroy cancer cells, but challenges such as toxicities, relapses, and immunologically cold tumors remain. New strategies are needed to improve efficacy, select appropriate therapies, and expand accessibility to more tumor types and patient populations.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2021)

Add to Collection

Article Nanoscience & Nanotechnology

Magnetic Targeting and Ultrasound Activation of Liposome-Microbubble Conjugate for Enhanced Delivery of Anticancer Therapies

Pankaj Dwivedi et al.

ACS APPLIED MATERIALS & INTERFACES (2020)

Add to Collection

Article Multidisciplinary Sciences

Ultrasound Molecular Imaging of Renal Cell Carcinoma: VEGFR targeted therapy monitored with VEGFR1 and FSHR targeted microbubbles

Alexandre Ingels et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Nanobowl-Supported Liposomes Improve Drug Loading and Delivery

Zhong-Jian Chen et al.

NANO LETTERS (2020)

Add to Collection

Review Chemistry, Multidisciplinary

Anticancer DOX delivery system based on CNTs: Functionalization, targeting and novel technologies

Alireza Yaghoubi et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Add to Collection

Article Medicine, General & Internal

Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC

Roy S. Herbst et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Medicine, General & Internal

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma

Thomas Powles et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Oncology

Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blocker

Zhengyi Wang et al.

CANCER MEDICINE (2020)

Add to Collection

Article Medicine, Research & Experimental

Ultrasound targeting of microbubble-bound anti PD-L1 mAb to enhance anti-tumor effect of cisplatin in cervical cancer xenografts treatment

Yao Ma et al.

LIFE SCIENCES (2020)

Add to Collection

Review Oncology

Targeting immunogenic cell death in cancer

Asma Ahmed et al.

MOLECULAR ONCOLOGY (2020)

Add to Collection

Article Medicine, Research & Experimental

Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues

Nicola Ingram et al.

THERANOSTICS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Sonodynamic Therapeutic Effects of Sonosensitizers with Different Intracellular Distribution Delivered by Hollow Nanocapsules Exhibiting Cytosol Specific Release

Ryoma Teranishi et al.

MACROMOLECULAR BIOSCIENCE (2019)

Add to Collection

Article Medicine, Research & Experimental

Doxorubicin and Anti-PD-L1 Antibody Conjugated Gold Nanoparticles for Colorectal Cancer Photochemotherapy

Fakhrossadat Emami et al.

MOLECULAR PHARMACEUTICS (2019)

Add to Collection

Review Biotechnology & Applied Microbiology

PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations

Yongshuai Jiang et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)

Add to Collection

Review Oncology

Advances in cancer immunotherapy 2019-latest trends

Stephan Kruger et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Medicine, Research & Experimental

Enhancing Nab-Paclitaxel Delivery Using Microbubble-Assisted Ultrasound in a Pancreatic Cancer Model

Diane Bressand et al.

MOLECULAR PHARMACEUTICS (2019)

Add to Collection

Review Oncology

Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives

T. Mocan et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2019)

Add to Collection

Article Hematology

Ultrasound Molecular Imaging of Atherosclerosis With Nanobodies Translatable Microbubble Targeting Murine and Human VCAM (Vascular Cell Adhesion Molecule) 1

Mukesh Punjabi et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

The suppressive effect of co-inhibiting PD-1 and CTLA-4 expression on H22 hepatomas in mice

Leilei Liang et al.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2018)

Add to Collection

Article Multidisciplinary Sciences

C-Terminal Residue of Ultrashort Peptides Impacts on Molecular Self-Assembly, Hydrogelation, and Interaction with Small-Molecule Drugs

Kiat Hwa Chan et al.

SCIENTIFIC REPORTS (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Cytokines in immunogenic cell death: Applications for cancer immunotherapy

Anne Showalter et al.

CYTOKINE (2017)

Add to Collection

Review Oncology

Immunogenic cell death and DAMPs in cancer therapy

Dmitri V. Krysko et al.

NATURE REVIEWS CANCER (2012)

Add to Collection

Review Immunology

Cardiomyocyte death in doxorubicin-induced cardiotoxicity

Yi-Wei Zhang et al.

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)

Add to Collection

Article Biochemistry & Molecular Biology

Calreticulin exposure dictates the immunogenicity of cancer cell death

Michel Obeid et al.

NATURE MEDICINE (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.